Perioperative Medical Consultation: A Contemporary Approach to Surgical Risk Assessment and Optimization

Dr Neeraj Manikath , claude.ai

Abstract

The perioperative medical consultation has evolved from a binary "clearance" paradigm to a nuanced risk stratification and optimization process. This review examines contemporary evidence-based approaches to preoperative assessment, emphasizing actionable recommendations that improve surgical outcomes. We discuss the inadequacy of traditional "clearance" terminology, outline the components of a high-value preoperative consultation note, review cardiac risk stratification in light of myocardial injury after noncardiac surgery (MINS/MICA), address perioperative management of chronic obstructive pulmonary disease and obstructive sleep apnea, and provide a practical algorithm for anticoagulation management. This article is designed for internists and trainees who perform perioperative consultations, offering evidence-based guidance alongside clinical pearls for optimizing patient outcomes.

The Consult Question: "Clear This Patient for Surgery" – Reframing the Perioperative Consult from a "Clearance" to a Risk Assessment and Optimization Plan

The Problem with "Clearance"

The phrase "clear for surgery" is deeply embedded in medical vernacular yet fundamentally flawed. It implies a binary outcome—safe or unsafe—when perioperative risk exists on a continuum. No physician can guarantee surgical safety, and the term "clearance" may create false reassurance or medicolegal vulnerability. More importantly, this terminology obscures the consultant's true value: identifying modifiable risk factors, stratifying risk to inform shared decision-making, and optimizing medical conditions to reduce perioperative morbidity.

Reframing the Consultation

The perioperative consultation should be reframed as a comprehensive risk assessment with optimization recommendations. This approach aligns with contemporary guidelines from the American College of Cardiology/American Heart Association (ACC/AHA) and the European Society of Cardiology/European Society of Anaesthesiology (ESC/ESA), which emphasize risk quantification rather than binary decision-making.

Pearl: Replace "Patient is cleared for surgery" with "This patient has been evaluated for perioperative risk. The estimated risk of major adverse cardiac events is X% based on [risk calculator]. The following interventions are recommended to optimize outcomes."

The Consultant's Role

The internist's role encompasses:

Risk Stratification: Using validated tools (RCRI, NSQIP, MICA score) to quantify cardiac and non-cardiac risks
Medical Optimization: Addressing modifiable factors such as glycemic control, volume status, anemia, and medication management
Communication: Engaging in shared decision-making with patients, surgeons, and anesthesiologists
Postoperative Planning: Recommending surveillance strategies for high-risk patients

Oyster: Patients with poor functional capacity (unable to climb two flights of stairs or walk four blocks) have significantly higher perioperative cardiac risk regardless of their risk factor profile. Functional capacity assessment is often more valuable than extensive testing.

The Elements of a High-Value Pre-Op Note: Beyond the Template, Focusing on Specific, Actionable Recommendations

The Template Trap

Many preoperative notes follow institutional templates that generate lengthy, checkbox-style documentation with minimal clinical utility. A high-value consultation note is concise, problem-focused, and provides specific guidance that alters management.

Key Components of a High-Value Note

1. Surgical Risk Context

Begin by documenting the procedure, its urgency, and inherent risk category (low, intermediate, or high risk according to ACC/AHA guidelines). Cardiac risk stratification differs dramatically between cataract surgery (low risk, <1% cardiac event rate) and open aortic aneurysm repair (high risk, >5% event rate).

2. Quantified Risk Assessment

Move beyond qualitative statements like "increased risk." Use validated calculators:

Revised Cardiac Risk Index (RCRI): Simple, validated for cardiac events
NSQIP Risk Calculator: Procedure-specific, estimates multiple outcomes including mortality, cardiac events, and pneumonia
MICA Score: Emerging tool incorporating natriuretic peptides

Example: "Using the NSQIP calculator for laparoscopic colectomy in this 72-year-old with diabetes and hypertension, estimated risks are: serious complication 8.9%, cardiac event 1.2%, pneumonia 2.1%."

3. Problem-Based Assessment

Rather than documenting every medical condition, focus on those impacting perioperative risk:

Cardiovascular: Specify functional capacity, active cardiac conditions (unstable angina, decompensated heart failure, severe valvular disease), and risk factors requiring modification.

Pulmonary: Document baseline function, optimization of inhaler therapy, and postoperative risk factors (upper abdominal/thoracic surgery, smoking, prolonged anesthesia).

Renal: Perioperative acute kidney injury (AKI) significantly increases mortality. Document baseline function and recommend nephrotoxin avoidance, volume optimization, and hemodynamic monitoring for high-risk cases.

Endocrine: Glycemic targets (HbA1c <8% acceptable for most surgeries), thyroid status, and adrenal insufficiency risk requiring stress-dose steroids.

4. Medication Management

Provide explicit guidance:

Continue: Beta-blockers, statins, aspirin (for most cardiac patients)
Hold: Metformin (day of surgery for large procedures), SGLT-2 inhibitors (3 days preoperatively to reduce DKA risk), ACE inhibitors/ARBs (controversial, consider holding morning of surgery)
Bridge: Anticoagulation per algorithm (see section below)

Hack: Create a preoperative medication table in your note with three columns: Continue, Hold, and Bridge. This prevents omissions and improves clarity.

5. Specific, Actionable Recommendations

Avoid vague statements like "optimize cardiac status" or "routine monitoring." Instead:

✗ "Postoperative monitoring recommended"
✓ "Recommend continuous telemetry for 48 hours postoperatively with daily troponin measurements given RCRI score of 3"
✗ "Optimize pulmonary status"
✓ "Initiate tiotropium 5 mcg daily and continue albuterol. Ensure incentive spirometry and early mobilization postoperatively. Consider chest physiotherapy if productive cough develops."

Pearl: The best consultation notes answer the question "What specifically should I do differently because of this consultation?" If your recommendations don't change management, reconsider their value.

Cardiac Risk Stratification in the Era of MICA: When to Stress Test and When It's Unnecessary

The Overuse of Preoperative Stress Testing

Preoperative cardiac testing is frequently overutilized. The ACC/AHA guidelines emphasize that testing should only be performed if results will change management. Most patients do not require stress testing before noncardiac surgery.

When Stress Testing Is Unnecessary

Do NOT stress test if:

Low-risk surgery: Procedures with cardiac event rates <1% (cataract, endoscopy, superficial procedures)
Adequate functional capacity: Patients achieving ≥4 METs without symptoms (can climb two flights of stairs, perform moderate housework) have low cardiac risk regardless of risk factors
Recent evaluation: Stress test or coronary angiography within 2 years with no interval change in symptoms
Urgent surgery: Testing delays necessary procedures without proven benefit

Oyster: A 65-year-old diabetic with hypertension who plays tennis twice weekly does not need stress testing before elective orthopedic surgery, despite having multiple RCRI risk factors. Functional capacity assessment trumps risk factor counting.

When to Consider Stress Testing

Stress testing may be appropriate when:

Poor or unknown functional capacity AND elevated clinical risk (≥3 RCRI factors) undergoing intermediate/high-risk surgery
Results will change management: Patient and surgeon willing to delay surgery for revascularization if indicated
Active cardiac symptoms: Unstable angina or worsening dyspnea warrant evaluation regardless of planned surgery

Pearl: The most common indication for revascularization before noncardiac surgery is the same as in any patient: unstable symptoms or high-risk anatomy (left main disease, severe three-vessel disease). Prophylactic revascularization for stable coronary disease does not reduce perioperative events and delays surgery unnecessarily.

Myocardial Injury After Noncardiac Surgery (MINS/MICA)

Recent evidence highlights that most perioperative myocardial injury occurs without symptoms. MINS, defined as elevated troponin during or within 30 days after noncardiac surgery, occurs in 8-18% of patients and independently predicts mortality.

The MICA Score incorporates age, type of surgery, and preoperative natriuretic peptides (BNP/NT-proBNP) to identify patients at elevated MINS risk. Elevated natriuretic peptides (NT-proBNP >300 pg/mL or BNP >92 pg/mL) increase risk substantially.

Practical Application of MICA Concepts

For patients with elevated MICA risk:

Preoperative natriuretic peptides: Consider measurement in patients aged >65, or aged 45-64 with cardiovascular disease undergoing intermediate/high-risk surgery
Postoperative troponin surveillance: Daily troponin for 48-72 hours in high-risk patients enables early detection and management of MINS
Medical optimization: Ensure continuation of cardioprotective medications (beta-blockers, statins)

Hack: For patients with RCRI ≥1 undergoing major surgery, order: "Troponin daily × 3 days postoperatively. Notify MD if elevated above 99th percentile." This simple intervention enables early MINS detection.

Pearl: Beta-blockers should be continued in patients already taking them but should NOT be initiated immediately preoperatively in beta-blocker-naïve patients, as this increases stroke risk. If beta-blockade is indicated, initiate 2-4 weeks preoperatively with careful titration.

The COPD/OSA Patient: Optimizing Inhalers and Ensuring CPAP Compliance

Pulmonary Risk Assessment

Postoperative pulmonary complications (pneumonia, respiratory failure, prolonged mechanical ventilation) are as common as cardiac complications and equally contribute to mortality. Key risk factors include:

Procedure-related: Upper abdominal, thoracic, or vascular surgery; prolonged operative time (>3 hours); general anesthesia
Patient-related: COPD, OSA, obesity, current smoking, poor functional status

COPD Optimization

Preoperative Assessment:

Severity stratification: Review spirometry if available, assess exacerbation frequency, and evaluate current symptom control
Inhaler therapy review: Many patients use inhalers incorrectly or suboptimally

Optimization Strategy:

For all COPD patients undergoing intermediate/high-risk surgery:

Ensure long-acting bronchodilator therapy (LABA, LAMA, or combination)
Consider 7-10 day course of systemic corticosteroids if recent exacerbation or poor baseline control (controversial; individualize based on patient)
Smoking cessation (ideally >4 weeks preoperatively, though even shorter periods provide benefit)

Specific recommendations:

GOLD 1-2 (mild-moderate): LABA/LAMA combination (e.g., umeclidinium/vilanterol, tiotropium/olodaterol)
GOLD 3-4 (severe-very severe) or frequent exacerbations: Add inhaled corticosteroid (triple therapy: ICS/LABA/LAMA)

Pearl: Verify inhaler technique. Up to 70% of patients use inhalers incorrectly. Demonstration and teach-back improve outcomes. Document: "Inhaler technique verified and corrected."

Postoperative Pulmonary Risk Reduction

Document specific orders:

Incentive spirometry (10 breaths/hour while awake)
Chest physiotherapy if high risk
Early mobilization (out of bed postoperative day 1 if possible)
Continue bronchodilators throughout perioperative period
Avoid oversedation and respiratory depressants

Hack: For upper abdominal or thoracic surgery in COPD patients, recommend epidural analgesia if feasible. Superior pain control improves respiratory mechanics and reduces pulmonary complications compared with systemic opioids.

Obstructive Sleep Apnea Management

OSA affects 15-30% of surgical patients and increases risk of postoperative complications including respiratory failure, cardiac events, and delirium.

Preoperative Screening:

Use STOP-BANG score (≥3 indicates high OSA risk):

Snoring
Tiredness
Observed apnea
Pressure (hypertension)
BMI >35
Age >50
Neck circumference >40 cm
Gender (male)

Management:

Known OSA with CPAP: Verify compliance (insurance data or device download). Bring CPAP to hospital for immediate postoperative use
Suspected but undiagnosed OSA: Polysomnography is not required preoperatively, but implement perioperative precautions
Positioning: 30-45 degree head elevation reduces obstruction

Specific Orders:

"Patient has OSA (or high STOP-BANG score). Recommendations:

Use CPAP postoperatively at home settings (pressure X cm H₂O) immediately in PACU and throughout hospitalization
Elevate head of bed 30-45 degrees
Continuous pulse oximetry for 24 hours
Minimize opioids; consider multimodal analgesia (acetaminophen, NSAIDs, regional anesthesia)
If opioids required, use shorter-acting agents and monitor closely"

Oyster: Postoperative opioids in OSA patients significantly increase airway obstruction risk. Advocate strongly for multimodal analgesia and regional techniques. The safest opioid dose in an OSA patient is the lowest dose that controls pain.

The Anticoagulation Bridge: A Practical Algorithm Based on Bleeding vs. Thrombotic Risk

The Bridging Dilemma

Bridging anticoagulation—replacing warfarin or DOACs with short-acting heparin—was once routine but is now recognized as unnecessary for most patients. The BRIDGE trial demonstrated that bridging increases bleeding without reducing thromboembolism in atrial fibrillation patients undergoing procedures.

Step 1: Assess Thrombotic Risk

Atrial Fibrillation:

Calculate CHA₂DS₂-VASc score:

Low risk (score 0-2 in men, 0-3 in women): No bridging
Moderate risk (score 3-4): No bridging for most patients
High risk (score ≥5, or mechanical valve, recent VTE): Consider bridging selectively

Venous Thromboembolism:

Low risk: VTE >12 months ago, no recurrence → No bridging
Moderate risk: VTE 3-12 months ago → Usually no bridging
High risk: VTE within 3 months, recurrent VTE, severe thrombophilia (antiphospholipid syndrome, active cancer with VTE) → Consider bridging

Mechanical Heart Valves:

High risk: Mitral position, older-generation valve (ball-cage, tilting disc), history of thromboembolism → Bridge
Lower risk: Bileaflet aortic valve, no other risk factors → Consider no bridging

Step 2: Assess Bleeding Risk

High bleeding risk procedures:

Intracranial, spinal, or posterior eye surgery
Major cancer surgery (especially GI, GU)
Cardiac or vascular surgery
Extensive soft tissue dissection

Low bleeding risk procedures:

Cataract surgery
Dental procedures
Endoscopy without biopsy
Dermatologic procedures

Step 3: Decision Algorithm

For Warfarin:

Low/moderate thrombotic risk + any bleeding risk OR high bleeding risk procedure: Stop warfarin 5 days preoperatively, no bridging, resume 12-24 hours postoperatively when hemostasis secure
High thrombotic risk + low bleeding risk: Stop warfarin 5 days preoperatively, bridge with LMWH (enoxaparin 1 mg/kg SC q12h or dalteparin 100 units/kg SC q12h), last dose 24 hours before surgery, resume bridging and warfarin postoperatively when hemostasis secure
High thrombotic risk + high bleeding risk: Individualize, consider delaying surgery for risk factor optimization, or proceed without bridging with intensive monitoring

For DOACs:

DOACs have short half-lives (8-15 hours), making bridging unnecessary for virtually all patients:

Normal renal function + low bleeding risk: Hold 1-2 days before surgery (dabigatran 2 days, others 1 day)
Normal renal function + high bleeding risk: Hold 2-4 days before surgery (dabigatran 3-4 days, others 2-3 days)
Resume postoperatively: When hemostasis is secure (typically 24-72 hours depending on bleeding risk)

Hack: Create a bridging order set template:

Anticoagulation Management for [Procedure]:
Indication: [AF/VTE/Mechanical valve]
Thrombotic risk: [Low/Moderate/High]
Bleeding risk: [Low/High]

Plan:
□ Stop warfarin/DOAC on [date], 5 days before surgery
□ No bridging OR Bridge with enoxaparin 1 mg/kg SC q12h starting [date]
□ Last enoxaparin dose [date/time], 24 hours before surgery
□ Resume warfarin [date] postoperatively
□ Resume enoxaparin when hemostasis secure, approximately 24 hours postop
□ Check INR on postop day 3 and daily until therapeutic
□ Discontinue enoxaparin when INR therapeutic × 2 measurements

Special Considerations

Aspirin/P2Y12 Inhibitors:

Continue aspirin perioperatively for most patients (including those with coronary stents)
P2Y12 inhibitors (clopidogrel, ticagrelor, prasugrel): Continue if <6 months from coronary stent placement, hold 5-7 days if possible for high bleeding risk procedures beyond this window
DAPT (dual antiplatelet therapy) should continue for at least 30 days after bare-metal stent, 6 months after drug-eluting stent

Pearl: In patients with recent coronary stents, postponing elective surgery until the appropriate DAPT duration is complete is almost always safer than interrupting antiplatelet therapy. Surgery within 6 months of stent placement substantially increases stent thrombosis and mortality risk.

Conclusion

The perioperative medical consultation demands sophisticated risk assessment, evidence-based optimization, and clear communication. By reframing the consult from "clearance" to comprehensive risk stratification, focusing documentation on actionable recommendations, applying contemporary cardiac risk assessment tools including MICA concepts, optimizing pulmonary function in COPD and OSA, and implementing rational anticoagulation management strategies, internists can substantially improve surgical outcomes. The principles outlined in this review provide a framework for delivering high-value perioperative care that genuinely reduces morbidity and mortality rather than simply fulfilling bureaucratic requirements.

Key Clinical Pearls Summary

Replace "cleared for surgery" with quantified risk assessment
Functional capacity (≥4 METs) is often more valuable than extensive cardiac testing
Stress testing is rarely indicated for patients with good functional capacity
Beta-blockers: continue if already prescribed, do not initiate immediately preoperatively
Postoperative troponin surveillance detects MINS in high-risk patients
Verify and correct inhaler technique in all COPD patients
CPAP must be used immediately postoperatively in OSA patients
Most atrial fibrillation patients do not require bridging anticoagulation
DOACs rarely require bridging due to short half-lives
Continue aspirin perioperatively; avoid interrupting DAPT in patients with recent stents

References

Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation. 2014;130(24):e278-e333.
Kristensen SD, Knuuti J, Saraste A, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. Eur Heart J. 2014;35(35):2383-2431.
Duceppe E, Parlow J, MacDonald P, et al. Canadian Cardiovascular Society guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery. Can J Cardiol. 2017;33(1):17-32.
Botto F, Alonso-Coello P, Chan MT, et al. Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology. 2014;120(3):564-578.
Devereaux PJ, Duceppe E, Guyatt G, et al. Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial. Lancet. 2018;391(10137):2325-2334.
Douketis JD, Spyropoulos AC, Kaatz S, et al. Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med. 2015;373(9):823-833.
Canet J, Gallart L, Gomar C, et al. Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology. 2010;113(6):1338-1350.
Qaseem A, Snow V, Fitterman N, et al. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians. Ann Intern Med. 2006;144(8):575-580.
Chung F, Memtsoudis SG, Ramachandran SK, et al. Society of Anesthesia and Sleep Medicine guidelines on preoperative screening and assessment of adult patients with obstructive sleep apnea. Anesth Analg. 2016;123(2):452-473.
Wijeysundera DN, Duncan D, Nkonde-Price C, et al. Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. J Am Coll Cardiol. 2014;64(22):2406-2425.
Bilimoria KY, Liu Y, Paruch JL, et al. Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg. 2013;217(5):833-842.
Wijeysundera DN, Pearse RM, Shulman MA, et al. Assessment of functional capacity before major non-cardiac surgery: an international, prospective cohort study. Lancet. 2018;391(10140):2631-2640.

Corresponding Author Contact: [Journal standard format] Conflicts of Interest: None Funding: None

Search This Blog

Internal medicine